Key references: Mycobacterium avium complex (MAC) infection in adults with HIV infection
Chene G, Phillips A, Costagliola D, Sterne JAC, Furrer H, Del Amo J, et al. Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Int J Epidemiol 2017;46(3):797-n. https://www.ncbi.nlm.nih.gov/pubmed/27864413
Jung Y, Song KH, Choe PG, Park WB, Bang JH, Kim ES, et al. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis. Int J STD AIDS 2017;28(14):1426-32. https://www.ncbi.nlm.nih.gov/pubmed/28592210
Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Rockville, MD: Department of Health & Human Services USA; Accessed July 2021. https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-opportunistic-infection/whats-new-guidelines
Yangco BG, Buchacz K, Baker R, Palella FJ, Armon C, Brooks JT, et al. Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/muL who are virologically suppressed on cART? AIDS Patient Care STDS 2014;28(6):280-3. https://www.ncbi.nlm.nih.gov/pubmed/24833016
